No Data
No Data
Buy Ideas in Managed Care and Healthcare Facilities - Baird
Managed Care Poised for Long-term Growth Despite Recent Headwinds: Baird
Astrana Health Initiated at Outperform by Baird
Astrana Health Initiated at Outperform by Baird
Baird Initiates Coverage On Astrana Health With Outperform Rating, Announces Price Target of $54
Baird analyst Michael Ha initiates coverage on Astrana Health (NASDAQ:ASTH) with a Outperform rating and announces Price Target of $54.
Those Who Invested in Astrana Health (NASDAQ:ASTH) Five Years Ago Are up 153%
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. One great example is
Astrana Health, Inc. to Participate in Upcoming Investor Conferences
ALHAMBRA, Calif., May 28, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric,
No Data